Biotechnology - Rare diseases, Cell Therapeutics


Popular Filters

Cell Therapeutics initiates launch of Pixuvri in Europe


Following the European approval of the drug this spring (The Pharma Letter May 14), US biotech firm Cell…

BiotechnologyCell TherapeuticsEuropeMarkets & MarketingOncologyPixuvriRare diseases

Cell Therapeutics prepares for Pixuvri launch; posts 2nd-qtr results


US biotech firm Cell Therapeutics (Nasdaq: CTIC) yesterday reported second-quarter 2012 financial results…

BiotechnologyCell TherapeuticsFinancialMarkets & MarketingOncologypacritinibPixuvriRare diseasesResearchtosedostat

Back to top